Home > Insider Trading > Filing (0001179110-13-006939)

Filing Details

Accession Number:: 0001179110-13-006939
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-04-18 10:23:18
Reporting Period:: 2013-04-16

Filing Date:: 2013-04-18
Accepted Time:: 2013-04-18 10:23:18
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1477598	Omthera Pharmaceuticals Inc.	OMTH	Pharmaceutical Preparations (2834)	263797738

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1441261	Fcpr Vi Capital Sofinnova	17, Rue De Serene Paris I0 75008		No	No	Yes	No
1574139	Sas Partners Sofinnova	17, Rue De Serene Paris I0 75008		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2013-04-16	5,745,044	$0.00	5,745,044	No	4	C	Direct
Common Stock	Acquisiton	2013-04-16	156,250	$0.01	5,901,294	No	4	C	Direct
Common Stock	Disposition	2013-04-16	196	$8.00	5,901,098	No	4	S	Direct
Common Stock	Acquisiton	2013-04-16	633,219	$8.00	6,534,317	No	4	C	Direct
Common Stock	Acquisiton	2013-04-16	625,000	$8.00	7,159,317	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	C	Direct
No	4	C	Direct
No	4	S	Direct
No	4	C	Direct
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Convertible Preferred Stock	Disposition	2013-04-16	4,350,000	$0.00	3,117,609	$0.00
Common Stock	Series B Convertible Preferred Stock	Disposition	2013-04-16	3,666,061	$0.00	2,627,435	$0.00
Common Stock	Warrant (right to buy)	Disposition	2013-04-16	156,250	$0.00	156,250	$0.01
Common Stock	Secured Convertible Promissory Note	Disposition	2013-04-16	633,219	$0.00	633,219	$8.00

Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
		No	4	C	Direct
		No	4	C	Direct
2013-04-16	2023-02-15	No	4	C	Direct
2013-04-16	2014-02-15	No	4	C	Direct

Footnotes

Represents the total number of shares received upon conversion of shares of the Issuer's Series A Convertible Preferred Stock (the "Series A Shares") and Series B Convertible Preferred Stock (the "Series B Shares" and together with the Series A Shares, the "Preferred Shares").
Sofinnova Partners SAS is the managing company of Sofinnova Capital VI FCPR and disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein, if any.
Represents the total number of shares received upon conversion of the reporting person's warrant.
Effective upon the closing of the Issuer's initial public offering ("IPO") of its Common Stock, the reporting person's warrant automatically converted into 156,250 shares of Common Stock. The reporting person paid the exercise price of $0.01 per share of the warrant on a cashless basis, resulting in the Issuer's withholding of 196 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 156,054 shares.
Represents the total number of shares received upon conversion of the Secured Convertible Promissory Note issued to the reporting person.
Effective upon the closing of the Issuer's IPO of its Common Stock, each Preferred Share automatically converted at a ratio of 1.3953-to-1 into the number of shares of Common Stock shown in column 7. The Preferred Shares had no expiration date.
This is the maturity date of the Secured Convertible Promissory Note.
The Secured Convertible Promissory Note was issued to the reporting person in exchange for $5,000,000. Effective upon the closing of the Issuer's IPO of its Common Stock, the Secured Convertible Promissory Note automatically converted into the number of shares of Common Stock shown in column 7.